The forefront of ovarian cancer therapy: update on PARP inhibitors. Mirza MR, Coleman RL, Gonzalez-Martin A, Moore KN, et al. Ann Oncol 2020 Jun 19. pii: S0923-7534(20)39891.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mirza MR, Coleman RL, Gonzalez-Martin A, Moore KN, et al. The forefront of ovarian cancer therapy: update on PARP inhibitors. Ann Oncol 2020 Jun 19. pii: S0923-7534(20)39891.
PMID: 32569725